Mounjaro and Sleep Apnea: What the Research Suggests

Obstructive sleep apnea is strongly associated with excess body weight. Fatty tissue around the upper airway can narrow the passages that keep breathing regular during sleep, and weight loss — through any means — is consistently recognised as a key factor in managing the condition.

Clinical research has explored whether tirzepatide, the active substance in Mounjaro, may reduce the severity of obstructive sleep apnea in adults with obesity. Trial data published in 2024 reported meaningful reductions in apnea-hypopnea index (AHI) scores among participants using tirzepatide compared with placebo. These are encouraging findings, but they come from a controlled trial setting; individual results vary considerably, and the medicine's effect on sleep apnea in any one person depends on many factors that only a prescriber can assess.

It is also worth noting that Mounjaro is a prescription-only medicine. Its use and any adjustments to it — including whether it may benefit your sleep apnea specifically — must be guided by the clinician who prescribed it to you. The medicine acts on GLP-1 and GIP receptors, influencing appetite regulation and metabolism; weight reduction that may follow is one of several mechanisms thought to be relevant to sleep apnea outcomes.

If you are also being treated for sleep apnea (for example, using a CPAP device), do not change that treatment on the basis of weight changes alone without first speaking to your healthcare professional.

For a closer look at how Mounjaro may relate to sleep quality more broadly, see our page on Mounjaro and sleep, or explore Mounjaro and sleep apnea in more detail. If you are managing a condition alongside your weight, the page on Mounjaro for people with diabetes may also be relevant to how your prescriber approaches your overall care.

One of the most useful things you can do while on Mounjaro is build a clear picture of how your health is changing over time — and sleep is a central part of that picture. GLP Trackr's daily check-in lets you log sleep alongside mood, energy levels, and weight each morning, so patterns become visible in a way that a rough memory never could.

Over weeks and months, that log can become genuinely valuable: if your sleep quality is shifting — whether improving or not — having a documented record means you can bring something concrete to your next appointment rather than relying on a general impression. The app's insights feature helps surface correlations across your data, so you can see whether the nights you slept better align with other changes in your journey.

The weight tracking and weekly progress charts in GLP Trackr also let you observe your body's changes in full — not just the number on the scale, but how that progression looks over time. For anyone monitoring a weight-related condition such as sleep apnea, this kind of consistent, longitudinal record is far more informative than occasional weigh-ins.

Always follow your prescriber's or doctor's guidance on both your Mounjaro dose and any treatment you use for sleep apnea. GLP Trackr is a tracking tool, not a medical service — it helps you record your journey clearly so you can discuss it with the professionals who know your full history. For broader information about Mounjaro and what to expect on your journey, visit our Mounjaro guide.

Start logging your sleep, energy, and progress today — GLP Trackr is free to try for 7 days on the App Store and Google Play.